Winchester, MA, United States of America

Athan Kuliopulos

USPTO Granted Patents = 11 (Patent Applications = 8)

CIPO Patents = 3

EPO Patents = 4 (Patent Applications = 8)

Average Co-Inventor Count = 2.0

ph-index = 4

Forward Citations = 71(Granted Patents)

Location History:

Winchester, MA (US) (2005 - 2018)
Boston, MA (US) (2021)

Company Filing History:

New England Medical Center Hospitals. Inc.

patents

1 out of 2

Anchor Therapeutics, Inc.

patents

Years Active: 2005-2021

Loading Chart...

11 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10913781 - Pepducin design and use (2021-02-09),

2. 9878054 - Polypeptide and lipophilic moiety conjugate compositions, formulations, and uses related thereto (2018-01-30),

3. 9376499 - PAR-1 activation by metalloproteinase-1 (MMP-1) (2016-06-28),

4. 9096646 - CXCR4 receptor compounds (2015-08-04),

5. 8563519 - Methods of activating or inhibiting G protein coupled receptors (GPCRs) (2013-10-22),

6. 8440627 - G protein coupled receptor agonists and antagonists and methods of use (2013-05-14),

7. 8389480 - G protein coupled receptor agonists and antagonists and methods of activating and inhibiting G protein coupled receptors using the same (2013-03-05),

8. 8354378 - G protein coupled receptor antagonists and methods of activating and inhibiting G protein coupled receptors using the same (2013-01-15),

9. 8324172 - G protein coupled receptor agonists and antagonists and methods of activating and inhibiting G protein coupled receptors using the same (2012-12-04),

10. 7696168 - G protein coupled receptor agonists and antagonists and methods of activating and inhibiting G protein coupled receptors using the same (2010-04-13),

11. 6864229 - G protein coupled receptor (GPCR) agonists and antagonists and methods of activating and inhibiting GPCR using the same (2005-03-08),

Title: Athan Kuliopulos: Innovator in Pharmaceutical Formulations

Introduction

Athan Kuliopulos is a notable inventor based in Winchester, MA (US). He has made significant contributions to the field of pharmaceutical formulations, holding a total of 11 patents. His work focuses on the rational design and application of GPCR antagonists and innovative drug formulations.

Latest Patents

Among his latest patents is the design and use of pepducins, which are potent and specific GPCR antagonists based on GPCR regions such as the third intracellular loop and adjacent areas. Another significant patent involves polypeptide and lipophilic moiety conjugate compositions, which relate to pharmaceutical formulations suitable for injection into humans and other animals. This patent outlines a method of preparing the formulation that includes lyophilizing, solubilizing in ammonium acetate, filtering to create mono-disperse particles, re-lyophilizing, and solubilizing the micelles in a dextrose solution for injection.

Career Highlights

Athan Kuliopulos has worked with esteemed organizations such as Tufts Medical Center, Inc. and New England Medical Center Hospitals, Inc. His experience in these institutions has allowed him to develop and refine his innovative ideas in the pharmaceutical sector.

Collaborations

Throughout his career, Kuliopulos has collaborated with notable colleagues, including Lidija Covic and Thomas J McMurry. These partnerships have contributed to the advancement of his research and inventions.

Conclusion

Athan Kuliopulos is a distinguished inventor whose work in pharmaceutical formulations has led to significant advancements in the field. His innovative patents and collaborations highlight his commitment to improving healthcare through scientific research and development.

This text is generated by artificial intelligence and may not be accurate.